Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Abstract Background No consensus treatment has been reached for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial chemoembolization (TACE) have been recommended as effective options, but which is better remains unclear. This meta-analysis...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	BMC 2017-12-01
Cyfres:	BMC Cancer
Pynciau:	Hepatic resection Transarterial chemoembolization Hepatocellular carcinoma Portal vein tumor thrombus
Mynediad Ar-lein:	http://link.springer.com/article/10.1186/s12885-017-3895-z

Eitemau Tebyg

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
gan: Lv WF, et al.
Cyhoeddwyd: (2018-10-01)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
gan: Junwei Chen, et al.
Cyhoeddwyd: (2023-07-01)

Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
gan: Ran You, et al.
Cyhoeddwyd: (2024-09-01)

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
gan: Danbi Lee, et al.
Cyhoeddwyd: (2018-06-01)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
gan: Won-Gyom Choe, et al.
Cyhoeddwyd: (2018-01-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
gan: Yashwant Patidar, et al.
Cyhoeddwyd: (2021-04-01)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
gan: Xiaomi Li, et al.
Cyhoeddwyd: (2023-08-01)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
gan: Fangzhou Luo, et al.
Cyhoeddwyd: (2021-09-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
gan: Fei-Xiang Wu, et al.
Cyhoeddwyd: (2017-09-01)

Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis
gan: Zi-Han Zhang, et al.
Cyhoeddwyd: (2023-01-01)

Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
gan: Ling Li, et al.
Cyhoeddwyd: (2022-02-01)

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
gan: Jin-Kai Feng, et al.
Cyhoeddwyd: (2022-11-01)

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts
gan: Xia WL, et al.
Cyhoeddwyd: (2024-09-01)

Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus
gan: Yu Zhang, et al.
Cyhoeddwyd: (2022-01-01)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
gan: Moon Haeng Hur, et al.
Cyhoeddwyd: (2023-07-01)

Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus
gan: Aoran Dong, et al.
Cyhoeddwyd: (2023-12-01)

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
gan: Li SQ, et al.
Cyhoeddwyd: (2023-10-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Thrombosis: A Perspective on Survival
gan: Yadav Ajit, et al.
Cyhoeddwyd: (2014-11-01)

Comparison of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization versus transarterial chemoembolization and portal vein embolization for planned hepatectomy with insufficient future liver remnant
gan: Tai-Wei Ye, et al.
Cyhoeddwyd: (2024-08-01)

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
gan: Xiao-Hui Zhao, et al.
Cyhoeddwyd: (2022-10-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
gan: Su Jong Yu, et al.
Cyhoeddwyd: (2023-03-01)

Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis
gan: Jia Deng, et al.
Cyhoeddwyd: (2023-01-01)

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
gan: Huang Q, et al.
Cyhoeddwyd: (2020-09-01)

DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
gan: Junwei Chen, et al.
Cyhoeddwyd: (2022-11-01)

Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
gan: Saikang Tang, et al.
Cyhoeddwyd: (2024-07-01)

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
gan: Jiwon Yang, et al.
Cyhoeddwyd: (2024-09-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
gan: You-Bin Wang, et al.
Cyhoeddwyd: (2023-09-01)

Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
gan: Zhao XH, et al.
Cyhoeddwyd: (2023-02-01)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
gan: Shuling Chen, et al.
Cyhoeddwyd: (2019-04-01)

Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
gan: Jin Hyoung Kim, et al.
Cyhoeddwyd: (2024-10-01)

A Rare Case of Empyema Developed after Transarterial Chemoembolization for Hepatocellular Carcinoma
gan: Young Keun Sur, et al.
Cyhoeddwyd: (2015-01-01)

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
gan: Hiroki Higashihara, et al.
Cyhoeddwyd: (2021-10-01)

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
gan: Al Fuhaid Turki, et al.
Cyhoeddwyd: (2007-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
gan: Zhang W, et al.
Cyhoeddwyd: (2021-07-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
gan: Mahmoud Abu Elfadl, et al.
Cyhoeddwyd: (2019-01-01)

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
gan: Xiaodong Song, et al.
Cyhoeddwyd: (2020-08-01)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
gan: B. I. Dolgushin, et al.
Cyhoeddwyd: (2016-09-01)

Transileocolic Vein Obliteration for Bleeding Rectal Varices with Portal Thrombus
gan: Hirotaka Arai, et al.
Cyhoeddwyd: (2013-03-01)

A combination of portal vein stent insertion and endovascular iodine-125 seed-strip implantation, followed by transcatheter arterial chemoembolization with sorafenib for treatment of hepatocellular carcinoma-associated portal vein tumor thrombus
gan: Shuangxi Li, et al.
Cyhoeddwyd: (2021-12-01)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
gan: Zheng Y, et al.
Cyhoeddwyd: (2024-06-01)